← Open Payments lookup

NPI 1467516757: Open Payments

NPI 1467516757. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$133 in 6 payments from 5 companies in 2025. Trend: 2023 $232 · 2024 $409 · 2025 $133

Food & beverage: $133
CompanyPaymentsAmount
Lilly USA, LLC2$45
Smith+Nephew, Inc.1$24
Verona Pharma, Inc.1$23
Novo Nordisk Inc1$22
Exact Sciences Corporation1$19

Products named: MOUNJARO, RENASYS TOUCH, Ohtuvayre, Ozempic, Cologuard Collection Kit.